Pfizer Deploys Intranet-based StatServer Technology To Improve FDA Reporting
Abstract
Pfizer is devoted to discovering, developing, manufacturing, and marketing quality pharmaceutical products. Each year, the global pharmaceutical industry spends $40.1 billion on drug discovery, development and approval. Professional reporting with informative, precise graphics translating results can help FDA decision makers to bring safe, effective drugs to market sooner. Withthe use of S-PLUS researchers can prepare reports that are consistent, easy-to-read and translate results effectively. Better reports can help bring safe, effective drugs to market faster improving the quality of human lives.
Download